HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NDUFAF5
NADH:ubiquinone oxidoreductase complex assembly factor 5
Chromosome 20 Β· 20p12.1
NCBI Gene: 79133Ensembl: ENSG00000101247.19HGNC: HGNC:15899UniProt: Q5TEU4
40PubMed Papers
21Diseases
0Drugs
117Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
mitochondrionmitochondrial respiratory chain complex I assemblyprotein bindingmatrix side of mitochondrial inner membranemitochondrial complex I deficiencymitochondrial complex I deficiency, nuclear type 16mitochondrial diseaseLeigh syndrome
✦AI Summary

NDUFAF5 encodes an arginine hydroxylase that functions as a critical assembly factor for mitochondrial respiratory chain Complex I. The protein mediates hydroxylation of arginine-111 in the NDUFS7 subunit and is essential for early stages of Complex I assembly 1. NDUFAF5 contains a putative methyltransferase domain that is essential for its function, and site-directed mutagenesis studies confirm this motif's importance 2. The protein has been identified as a substrate for pp60Src kinase, with phosphorylation playing a role in Complex I activity and assembly 3. Biallelic mutations in NDUFAF5 cause mitochondrial Complex I deficiency leading to Leigh syndrome, with significant phenotypic heterogeneity observed among patients 14. The p.Met279Arg variant shows particular population specificity in Chinese ancestry and demonstrates age-dependent clinical severity, with early-onset cases presenting with severe neurodegeneration and late-onset cases showing progressive dystonia with preserved cognition 4. NDUFAF5 deficiency is also associated with increased autophagy activation, suggesting novel pathways beyond traditional AMPK-mediated mechanisms in mitochondrial disease pathology 2. Additionally, NDUFAF5 may play roles in cancer chemoresistance through ROS regulation pathways 5.

Sources cited
1
NDUFAF5 encodes a Complex I assembly factor critical for NDUFS7 modification and causes Leigh syndrome when mutated
PMID: 34797029
2
NDUFAF5 contains an essential methyltransferase domain and deficiency leads to increased autophagy
PMID: 23536703
3
NDUFAF5 is a pp60Src substrate involved in Complex I activity and assembly
PMID: 40332450
4
NDUFAF5 mutations show phenotypic heterogeneity with age-dependent severity, particularly the p.Met279Arg variant in Chinese populations
PMID: 37752895
5
NDUFAF5 is involved in ROS regulation pathways and cancer chemoresistance mechanisms
PMID: 38155279
Disease Associationsβ“˜21
mitochondrial complex I deficiencyOpen Targets
0.73Strong
mitochondrial complex I deficiency, nuclear type 16Open Targets
0.70Strong
mitochondrial diseaseOpen Targets
0.60Moderate
Leigh syndromeOpen Targets
0.59Moderate
mitochondrial complex I deficiency, nuclear type 1Open Targets
0.58Moderate
genetic disorderOpen Targets
0.39Weak
Leber plus diseaseOpen Targets
0.32Weak
neurodegenerative diseaseOpen Targets
0.16Weak
benign prostatic hyperplasiaOpen Targets
0.06Suggestive
cancerOpen Targets
0.06Suggestive
Abruptio PlacentaeOpen Targets
0.04Suggestive
JaundiceOpen Targets
0.03Suggestive
Alzheimer diseaseOpen Targets
0.03Suggestive
heart diseaseOpen Targets
0.03Suggestive
stricture or kinking of ureterOpen Targets
0.03Suggestive
chondrocalcinosisOpen Targets
0.02Suggestive
femur fractureOpen Targets
0.02Suggestive
alcohol drinkingOpen Targets
0.02Suggestive
neoplasmOpen Targets
0.01Suggestive
Leber hereditary optic neuropathyOpen Targets
0.01Suggestive
Mitochondrial complex I deficiency, nuclear type 16UniProt
Pathogenic Variants117
NM_024120.5(NDUFAF5):c.327G>C (p.Lys109Asn)Pathogenic
not provided|Inborn genetic diseases|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency, nuclear type 1|Mitochondrial complex I deficiency|Leigh syndrome|NDUFAF5-related disorder|Sarcoma|Uterine carcinosarcoma
β˜…β˜…β˜†β˜†2026β†’ Residue 109
NM_024120.5(NDUFAF5):c.836T>G (p.Met279Arg)Pathogenic
Inborn genetic diseases|Mitochondrial complex I deficiency|Leigh syndrome|Mitochondrial complex I deficiency, nuclear type 16|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 279
NM_024120.5(NDUFAF5):c.749G>T (p.Gly250Val)Pathogenic
Mitochondrial complex I deficiency, nuclear type 16|not provided|Mitochondrial complex I deficiency|NDUFAF5-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 250
NM_024120.5(NDUFAF5):c.826C>T (p.Arg276Ter)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2026β†’ Residue 276
NM_024120.5(NDUFAF5):c.1A>C (p.Met1Leu)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 1
NM_024120.5(NDUFAF5):c.30_31del (p.Cys11fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 16|not provided|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 11
NM_024120.5(NDUFAF5):c.717+1G>CLikely pathogenic
not provided|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025
NM_024120.5(NDUFAF5):c.24G>A (p.Trp8Ter)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 8
NM_024120.5(NDUFAF5):c.408dup (p.Ser137fs)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 137
NM_024120.5(NDUFAF5):c.552dup (p.Ile185fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 16|not provided|Leigh syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 185
NM_024120.5(NDUFAF5):c.223-907A>CPathogenic
Mitochondrial complex I deficiency, nuclear type 16|not provided|Leigh syndrome
β˜…β˜…β˜†β˜†2025
NM_024120.5(NDUFAF5):c.945+1G>ALikely pathogenic
Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025
NM_024120.5(NDUFAF5):c.44G>A (p.Trp15Ter)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 15
NM_024120.5(NDUFAF5):c.204del (p.Phe68fs)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 68
NM_024120.5(NDUFAF5):c.155A>C (p.Lys52Thr)Likely pathogenic
Inborn genetic diseases|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 52
NM_024120.5(NDUFAF5):c.183_190dup (p.Glu64fs)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 64
NM_024120.5(NDUFAF5):c.46del (p.Ala16fs)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 16
NM_024120.5(NDUFAF5):c.833_834del (p.Thr278fs)Pathogenic
not provided|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 278
NM_024120.5(NDUFAF5):c.33T>A (p.Cys11Ter)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 11
NM_024120.5(NDUFAF5):c.479+1G>ALikely pathogenic
Mitochondrial complex I deficiency, nuclear type 16|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2025
View on ClinVar β†—
Related Genes
TMEM186Shared pathway100%LYRM2Shared pathway100%DMAC1Shared pathway100%NDUFAF3Protein interaction100%FOXRED1Protein interaction100%NDUFA12Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Heart
54%
Brain
37%
Liver
24%
Lung
19%
Ovary
16%
Gene Interaction Network
Click a node to explore
NDUFAF5TMEM186LYRM2DMAC1NDUFAF3FOXRED1NDUFA12
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q5TEU4
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.07LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.73 [0.51–1.07]
RankingsWhere NDUFAF5 stands among ~20K protein-coding genes
  • #10,212of 20,598
    Most Researched40
  • #668of 5,498
    Most Pathogenic Variants117 Β· top quartile
  • #10,773of 17,882
    Most Constrained (LOEUF)1.07
Genes detectedNDUFAF5
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Targeting lncRNA16 by GalNAc-siRNA conjugates facilitates chemotherapeutic sensibilization via the HBB/NDUFAF5/ROS pathway.
PMID: 38155279
Sci China Life Sci Β· 2024
1.00
2
Case report of atypical Leigh syndrome in an adolescent male with novel biallelic variants in NDUFAF5 and review of the natural history of NDUFAF5-related disorders.
PMID: 34797029
Am J Med Genet A Β· 2022
0.90
3
Generation of a human induced pluripotent stem cell line NTUHi004-A from a patient with Leigh syndrome harboring a homozygous missense mutation c.836Β TΒ >Β G (p.Met279Arg) in NDUFAF5 gene.
PMID: 38458030
Stem Cell Res Β· 2024
0.80
4
Ndufaf5 deficiency in the Dictyostelium model: new roles in autophagy and development.
PMID: 23536703
Mol Biol Cell Β· 2013
0.70
5
Phenotypic Heterogeneity in Patients with Mutations in the Mitochondrial Complex I Assembly Gene NDUFAF5.
PMID: 37752895
Mov Disord Β· 2023
0.60